New

Acquisition Criteria

Commercial Development Company (CDC) actively seeks to acquire industrial-sector real estate assets valued from $5 Million to $500 Million USD throughout the United States and Canada.

Through a proven framework of underwriting strategies, CDC consistently discovers value where others may not and routinely tenders the highest and best offer for the real estate assets it targets. CDC has the vision, financial strength, and technical capabilities to underwrite and close difficult transactions efficiently and quickly.

Acquisition Criteria

Investment Categories

  • Industrial Complexes (All Types)
  • Corporate Campuses
  • Manufacturing Plants
  • Operational Manufacturing Companies
  • Government Installations
  • Military Installations
  • Operational or Closed Landfills
  • Operational or Closed Quarries
  • Operational or Closed Mines
  • Retail Centers
  • Raw Land
  • Renewable Energy Sites
  • Distribution Facilities
  • Notes & Mortgages

Common Real Estate Attributes

  • Clean or Environmentally Impacted
  • Individual Sites or Portfolios
  • Primary, Secondary or Tertiary Markets
  • Brownfields
  • Demolition & Redevelopment Sites
  • Repurpose & Retrofits
  • Bankruptcies & Bank Owned Properties
  • Otherwise Impaired
  • Income Producing or Vacant
  • Sale Leaseback

Acquisition Value Range per Transaction

  • $5 Million – $500 Million

Selected Transaction Partners

CDC has been trusted to purchase, assume liability, and redevelop real estate from clients including: Dynegy, General Motors (5), Bethlehem Steel, AEP (2), Solutia, WestRock (2), Emerald Performance Materials, Evraz Steel, Georgia Pacific, Shell Global (4), Alliant Energy, Ameren Energy, Fibrant, CertainTeed, Ingersoll-Rand, TEVA Pharmaceuticals, Asarco (2), DTE Energy, Akzo Nobel, Congoleum, Caterpillar, Chrysler Corporation, Kinder Morgan, Chemtura, ABB, Kaiser Aluminum, Uniroyal, BAE Systems, Trelleborg, and others.

Contact CDC

If you have a real estate asset that fits CDC’s acquisition criteria, please contact us for a confidential discussion.
Please enable JavaScript in your browser to complete this form.